{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:05:07Z","timestamp":1778857507899,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473151"],"award-info":[{"award-number":["82473151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovation Capability Support Project of Shaanxi Province","award":["2023KJXX\uff0d032, 2022PT-24"],"award-info":[{"award-number":["2023KJXX\uff0d032, 2022PT-24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13657-4","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:09:24Z","timestamp":1739189364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteomic profiling reveals biological processes and biomarkers involved in the pathogenesis of occult breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jingyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"12","key":"13657_CR1","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1002\/1097-0142(19810615)47:12<2923::AID-CNCR2820471231>3.0.CO;2-N","volume":"47","author":"J Patel","year":"1981","unstructured":"Patel J, et al. Axillary lymph node metastasis from an occult breast cancer. Cancer. 1981;47(12):2923\u20137.","journal-title":"Cancer"},{"issue":"3","key":"13657_CR2","first-page":"302","volume":"98","author":"HW Owen","year":"1954","unstructured":"Owen HW, Dockerty MB, Gray HK. Occult carcinoma of the breast. Surg Gynecol Obstet. 1954;98(3):302\u20138.","journal-title":"Surg Gynecol Obstet"},{"issue":"17","key":"13657_CR3","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1002\/cncr.25197","volume":"116","author":"GV Walker","year":"2010","unstructured":"Walker GV, et al. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer. 2010;116(17):4000\u20136.","journal-title":"Cancer"},{"issue":"6","key":"13657_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10434-000-0411-4","volume":"7","author":"JA Olson Jr","year":"2000","unstructured":"Olson JA Jr, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7(6):411\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"5\u20136","key":"13657_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000107111","volume":"71","author":"R Varadarajan","year":"2006","unstructured":"Varadarajan R, et al. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 2006;71(5\u20136):456\u20139.","journal-title":"Oncology"},{"issue":"6","key":"13657_CR6","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1245\/s10434-016-5104-8","volume":"23","author":"FI Macedo","year":"2016","unstructured":"Macedo FI, et al. Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis. Ann Surg Oncol. 2016;23(6):1838\u201344.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"13657_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12893-022-01472-8","volume":"22","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, et al. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study. BMC Surg. 2022;22(1):143.","journal-title":"BMC Surg"},{"key":"13657_CR8","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.2147\/CMAR.S169019","volume":"10","author":"LP Ge","year":"2018","unstructured":"Ge LP, et al. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study. Cancer Manag Res. 2018;10:4381\u201391.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"13657_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.suc.2007.01.002","volume":"87","author":"LA Newman","year":"2007","unstructured":"Newman LA, Singletary SE. Overview of adjuvant systemic therapy in early stage breast cancer. Surg Clin North Am. 2007;87(2):499\u2013509, xi.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"13657_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-009-0554-3","volume":"119","author":"G Pentheroudakis","year":"2010","unstructured":"Pentheroudakis G, Lazaridis G, Pavlidis N. Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. Breast Cancer Res Treat. 2010;119(1):1\u201311.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"13657_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/jso.23644","volume":"110","author":"G Sohn","year":"2014","unstructured":"Sohn G, et al. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study. J Surg Oncol. 2014;110(3):270\u20134.","journal-title":"J Surg Oncol"},{"issue":"5","key":"13657_CR12","first-page":"431","volume":"61","author":"B Jackson","year":"1995","unstructured":"Jackson B, Scott-Conner C, Moulder J. Axillary metastasis from occult breast carcinoma: diagnosis and management. Am Surg. 1995;61(5):431\u20134.","journal-title":"Am Surg"},{"issue":"4","key":"13657_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1634\/theoncologist.12-4-418","volume":"12","author":"G Pentheroudakis","year":"2007","unstructured":"Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: missing primary or missing biology? Oncologist. 2007;12(4):418\u201325.","journal-title":"Oncologist"},{"issue":"1","key":"13657_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-018-4898-4","volume":"172","author":"M Terada","year":"2018","unstructured":"Terada M, et al. Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes. Breast Cancer Res Treat. 2018;172(1):1\u20137.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"13657_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cell.2007.07.032","volume":"130","author":"J Cox","year":"2007","unstructured":"Cox J, Mann M. Is Proteomics the New Genomics? Cell. 2007;130(3):395\u20138.","journal-title":"Cell"},{"issue":"11","key":"13657_CR16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","volume":"102","author":"M Cui","year":"2022","unstructured":"Cui M, Cheng C, Zhang L. High-throughput proteomics: a methodological mini-review. Lab Invest. 2022;102(11):1170\u201381.","journal-title":"Lab Invest"},{"issue":"9","key":"13657_CR17","doi-asserted-by":"publisher","first-page":"101166","DOI":"10.1016\/j.xcrm.2023.101166","volume":"4","author":"Y Qu","year":"2023","unstructured":"Qu Y, et al. Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma. Cell Rep Med. 2023;4(9):101166.","journal-title":"Cell Rep Med"},{"issue":"6","key":"13657_CR18","doi-asserted-by":"publisher","first-page":"100661","DOI":"10.1016\/j.xcrm.2022.100661","volume":"3","author":"O Karayel","year":"2022","unstructured":"Karayel O, et al. Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease. Cell Rep Med. 2022;3(6):100661.","journal-title":"Cell Rep Med"},{"issue":"5","key":"13657_CR19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ccell.2020.08.002","volume":"38","author":"C Li","year":"2020","unstructured":"Li C, et al. Integrated Omics of Metastatic Colorectal Cancer. Cancer Cell. 2020;38(5):734-747.e9.","journal-title":"Cancer Cell"},{"issue":"1","key":"13657_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/path.5420","volume":"251","author":"F Coscia","year":"2020","unstructured":"Coscia F, et al. A streamlined mass spectrometry-based proteomics workflow for large-scale FFPE tissue analysis. J Pathol. 2020;251(1):100\u201312.","journal-title":"J Pathol"},{"issue":"12","key":"13657_CR21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier F, et al. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat Methods. 2020;17(12):1229\u201336.","journal-title":"Nat Methods"},{"issue":"43","key":"13657_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"13657_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181(3):362\u201374.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"13657_CR24","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1074\/mcp.M110.003020","volume":"9","author":"V Charoensawan","year":"2010","unstructured":"Charoensawan V, et al. The impact of gene expression regulation on evolution of extracellular signaling pathways. Mol Cell Proteomics. 2010;9(12):2666\u201377.","journal-title":"Mol Cell Proteomics"},{"issue":"23","key":"13657_CR25","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41388-024-03030-3","volume":"43","author":"X Chen","year":"2024","unstructured":"Chen X, et al. COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk. Oncogene. 2024;43(23):1742\u201356.","journal-title":"Oncogene"},{"issue":"2","key":"13657_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-022-06635-y","volume":"194","author":"F Sato","year":"2022","unstructured":"Sato F, et al. COL8A1 facilitates the growth of triple-negative breast cancer via FAK\/Src activation. Breast Cancer Res Treat. 2022;194(2):243\u201356.","journal-title":"Breast Cancer Res Treat"},{"key":"13657_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12935-020-01465-8","volume":"20","author":"W Peng","year":"2020","unstructured":"Peng W, et al. Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis. Cancer Cell Int. 2020;20:392.","journal-title":"Cancer Cell Int"},{"key":"13657_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbrc.2022.12.046","volume":"642","author":"A Sagara","year":"2023","unstructured":"Sagara A, et al. COL8A1 enhances the invasion\/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression. Biochem Biophys Res Commun. 2023;642:145\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"13657_CR29","doi-asserted-by":"crossref","unstructured":"Chastney MR, et al. The role and regulation of integrins in cell migration and invasion. Nat Rev Mol Cell Biol. 2025;26(2):147\u201367.","DOI":"10.1038\/s41580-024-00777-1"},{"issue":"11","key":"13657_CR30","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1158\/0008-5472.CAN-14-3485","volume":"75","author":"JG Parvani","year":"2015","unstructured":"Parvani JG, et al. Silencing \u03b23 Integrin by Targeted ECO\/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2015;75(11):2316\u201325.","journal-title":"Cancer Res"},{"issue":"1","key":"13657_CR31","first-page":"211","volume":"10","author":"IW Cheuk","year":"2020","unstructured":"Cheuk IW, et al. ITGAV targeting as a therapeutic approach for treatment of metastatic breast cancer. Am J Cancer Res. 2020;10(1):211\u201323.","journal-title":"Am J Cancer Res"},{"key":"13657_CR32","doi-asserted-by":"crossref","unstructured":"Smith BN, Bhowmick NA. Role of EMT in Metastasis and Therapy Resistance. J Clin Med. 2016;5(2):17.","DOI":"10.3390\/jcm5020017"},{"issue":"6","key":"13657_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13657_CR34","doi-asserted-by":"publisher","first-page":"113683","DOI":"10.1016\/j.biopha.2022.113683","volume":"155","author":"H Ding","year":"2022","unstructured":"Ding H, et al. Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway. Biomed Pharmacother. 2022;155:113683.","journal-title":"Biomed Pharmacother"},{"key":"13657_CR35","doi-asserted-by":"crossref","unstructured":"Habanjar O, et al. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. Int J Mol Sci. 2023;24(4):4002.","DOI":"10.3390\/ijms24044002"},{"issue":"6","key":"13657_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429\u201337.","journal-title":"J Clin Invest"},{"issue":"1","key":"13657_CR37","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s12888-022-04469-y","volume":"22","author":"J Soqia","year":"2022","unstructured":"Soqia J, et al. Depression, anxiety and related factors among Syrian breast cancer patients: a cross-sectional study. BMC Psychiatry. 2022;22(1):796.","journal-title":"BMC Psychiatry"},{"key":"13657_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.breast.2019.10.017","volume":"49","author":"H Kim","year":"2020","unstructured":"Kim H, et al. Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI. Breast. 2020;49:63\u20139.","journal-title":"Breast"},{"issue":"36","key":"13657_CR39","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.2217\/fon-2023-0685","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, et al. Occult breast cancer patients with mastectomy have better prognosis than those with breast-conserving therapy. Future Oncol. 2023;19(36):2405\u201316.","journal-title":"Future Oncol"},{"issue":"7","key":"13657_CR40","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017;171(7):1611-1624.e24.","journal-title":"Cell"},{"issue":"8","key":"13657_CR41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186(8):1564\u201379.","journal-title":"Cell"},{"key":"13657_CR42","doi-asserted-by":"crossref","unstructured":"Ma HP, et al. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis. Cancers (Basel). 2019;11(6):786.","DOI":"10.3390\/cancers11060786"},{"issue":"1","key":"13657_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12935-021-01982-0","volume":"21","author":"W Yin","year":"2021","unstructured":"Yin W, et al. Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma. Cancer Cell Int. 2021;21(1):276.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"13657_CR44","first-page":"651","volume":"76","author":"C Gilles","year":"1997","unstructured":"Gilles C, et al. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest. 1997;76(5):651\u201360.","journal-title":"Lab Invest"},{"key":"13657_CR45","doi-asserted-by":"crossref","unstructured":"Fujisaki H, Futaki S. Epithelial-Mesenchymal Transition Induced in Cancer Cells by Adhesion to Type I Collagen. Int J Mol Sci. 2022;24(1):198.","DOI":"10.3390\/ijms24010198"},{"key":"13657_CR46","doi-asserted-by":"publisher","first-page":"8963","DOI":"10.2147\/OTT.S259033","volume":"13","author":"Q An","year":"2020","unstructured":"An Q, et al. circKRT7-miR-29a-3p-COL1A1 Axis Promotes Ovarian Cancer Cell Progression. Onco Targets Ther. 2020;13:8963\u201376.","journal-title":"Onco Targets Ther"},{"key":"13657_CR47","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.2147\/OTT.S194568","volume":"12","author":"H Zhu","year":"2019","unstructured":"Zhu H, et al. Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer. Onco Targets Ther. 2019;12:3441\u201357.","journal-title":"Onco Targets Ther"},{"key":"13657_CR48","doi-asserted-by":"crossref","unstructured":"Marconi GD, et al. Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis. Cells. 2021;10(7):1587.","DOI":"10.3390\/cells10071587"},{"issue":"3","key":"13657_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.taap.2012.01.024","volume":"259","author":"M Tsubaki","year":"2012","unstructured":"Tsubaki M, et al. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529\/ONO-5920-induced blockade of the Ras\/MEK\/ERK and Ras\/PI3K\/Akt pathway. Toxicol Appl Pharmacol. 2012;259(3):402\u201310.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"728","key":"13657_CR50","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJ Sleeboom","year":"2024","unstructured":"Sleeboom JJ, et al. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets. Sci Transl Med. 2024;16(728):eadg3840.","journal-title":"Sci Transl Med."},{"key":"13657_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.08.003","volume":"62","author":"K Karamanou","year":"2020","unstructured":"Karamanou K, et al. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. Semin Cancer Biol. 2020;62:125\u201333.","journal-title":"Semin Cancer Biol"},{"key":"13657_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2020.12.011","volume":"514","author":"S Appunni","year":"2021","unstructured":"Appunni S, et al. Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum. Clin Chim Acta. 2021;514:1\u20137.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"13657_CR53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17(1):309.","journal-title":"J Transl Med"},{"issue":"5","key":"13657_CR54","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ijc.33985","volume":"151","author":"R Shi","year":"2022","unstructured":"Shi R, et al. Targeting type I collagen for cancer treatment. Int J Cancer. 2022;151(5):665\u201383.","journal-title":"Int J Cancer"},{"key":"13657_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12935-017-0443-5","volume":"17","author":"S Liu","year":"2017","unstructured":"Liu S, Liao G, Li G. Regulatory effects of COL1A1 on apoptosis induced by radiation in cervical cancer cells. Cancer Cell Int. 2017;17:73.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"13657_CR56","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.ajpath.2015.01.029","volume":"185","author":"BK Brisson","year":"2015","unstructured":"Brisson BK, et al. Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer. Am J Pathol. 2015;185(5):1471\u201386.","journal-title":"Am J Pathol"},{"issue":"5","key":"13657_CR57","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891\u2013906.","journal-title":"Cell"},{"key":"13657_CR58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","volume":"62","author":"V Mohan","year":"2020","unstructured":"Mohan V, Das A, Sagi I. Emerging roles of ECM remodeling processes in cancer. Semin Cancer Biol. 2020;62:192\u2013200.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"13657_CR59","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-22-2034","volume":"83","author":"D De Martino","year":"2023","unstructured":"De Martino D, Bravo-Cordero JJ. Collagens in Cancer: Structural Regulators and Guardians of Cancer Progression. Cancer Res. 2023;83(9):1386\u201392.","journal-title":"Cancer Res"},{"issue":"7886","key":"13657_CR60","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun X, et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature. 2021;599(7886):673\u20138.","journal-title":"Nature"},{"key":"13657_CR61","doi-asserted-by":"crossref","unstructured":"de Almeida LG, et al. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacol Rev. 2022;74(3):712\u201368.","DOI":"10.1124\/pharmrev.121.000349"},{"issue":"3","key":"13657_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1215\/15228517-2008-001","volume":"10","author":"R Du","year":"2008","unstructured":"Du R, et al. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 2008;10(3):254\u201364.","journal-title":"Neuro Oncol"},{"issue":"6","key":"13657_CR63","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1158\/0008-5472.CAN-09-3515","volume":"70","author":"LE Littlepage","year":"2010","unstructured":"Littlepage LE, et al. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res. 2010;70(6):2224\u201334.","journal-title":"Cancer Res"},{"issue":"1","key":"13657_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12885-021-07860-2","volume":"21","author":"H Jiang","year":"2021","unstructured":"Jiang H, Li H. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):149.","journal-title":"BMC Cancer"},{"key":"13657_CR65","doi-asserted-by":"publisher","first-page":"45138","DOI":"10.1038\/srep45138","volume":"7","author":"K Karamanou","year":"2017","unstructured":"Karamanou K, et al. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition. Sci Rep. 2017;7:45138.","journal-title":"Sci Rep"},{"key":"13657_CR66","doi-asserted-by":"crossref","unstructured":"Giatagana EM, et al. Lumican in Carcinogenesis-Revisited. Biomolecules. 2021;11(9):1319.","DOI":"10.3390\/biom11091319"},{"issue":"4","key":"13657_CR67","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, et al. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017;168(4):707\u201323.","journal-title":"Cell"},{"issue":"1","key":"13657_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41423-018-0027-x","volume":"16","author":"SS Wang","year":"2019","unstructured":"Wang SS, et al. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. Cell Mol Immunol. 2019;16(1):6\u201318.","journal-title":"Cell Mol Immunol"},{"issue":"17","key":"13657_CR69","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.1158\/0008-5472.CAN-06-3889","volume":"67","author":"M Mizukami","year":"2007","unstructured":"Mizukami M, et al. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice. Cancer Res. 2007;67(17):8351\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"13657_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13657-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13657-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13657-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:46:46Z","timestamp":1739191606000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13657-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13657"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13657-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"13 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the Ethical Review Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University (No: XJTU1AF2024LSYY-095). All the patients involved in the proteomics study provided a written informed consent for the use of their tumor tissue for future scientific research. Given that the data from the SEER database are publicly available, we did not require informed patient consent in this retrospective population-based cohort study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}